In response to its cognate ligand CXCL12, CD45+ circulating immune cells from sarcoidosis patients exhibited approximately 2-fold greater cell migration compared with CD45+ immune cells from healthy volunteers (Figure 7D). This evidence concerns the gene PTPRC and sarcoidosis.